The formation of argpyrimidine, a methylglyoxal-arginine adduct, in the nucleus of neural cells

Biochemical and Biophysical Research Communications

Volumn 378, Issue 2, 2009, Pages 209-212

  Nakadate, Yusuke ^a   Uchida, Koji ^b   Shikata, Keiji ^a   Yoshimura, Saori ^a   Azuma, Masayuki ^a   Hirata, Tatsumi ^c   Konishi, Hiroyuki ^d   Kiyama, Hiroshi ^d   Tachibana, Taro ^a  

^a Osaka Prefecture University   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Argpyrimidine; Cerebral cortex; Development; Glyoxalase I; Methylglyoxal; Protein modification

Indexed keywords

ARGININE DERIVATIVE; ARGPYRIMIDINE; LACTOYLGLUTATHIONE LYASE; MESSENGER RNA; METHYLGLYOXAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL DIFFERENTIATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; DETOXIFICATION; DNA ADDUCT; GLYCOLYSIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOLECULAR STABILITY; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ANIMALS; ARGININE; CELL NUCLEUS; CEREBRAL CORTEX; DNA ADDUCTS; LACTOYLGLUTATHIONE LYASE; MICE; MICE, INBRED ICR; NEURONS; ORNITHINE; PYRIMIDINES; PYRUVALDEHYDE;

EID: 57049095822     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.028     Document Type: Article

References (24)

1. Thornalley P.J. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem. J. 269 (1990) 1-11
2. Thornalley P.J. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification - a role in pathogenesis and antiproliferative chemotherapy. Gen. Pharmacol. 27 (1996) 565-573
3. Kalapos M.P. Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol. Lett. 110 (1999) 145-175
4. Ranganathan S., Walsh E.S., and Tew K.D. Glyoxalase I in detoxification: studies using a glyoxalase I transfectant cell line. Biochem. J. 309 (1995) 127-131
5. Lo T.W., Westwood M.E., McLellan A.C., Selwood T., and Thornalley P.J. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. J. Biol. Chem. 269 (1994) 32299-32305
6. Thornalley P.J., Hooper N.I., Jennings P.E., Florkowski C.M., Jones A.F., Lunec J., and Barnett A.H. The human red blood cell glyoxalase system in diabetes mellitus. Diabetes Res. Clin. Pract. 7 (1989) 115-120
7. Cheng R., Lin B., and Ortwerth B.J. Rate of formation of AGEs during ascorbate glycation and during aging in human lens tissue. Biochim. Biophys. Acta 1587 (2002) 65-74
8. Oya T., Hattori N., Mizuno Y., Miyata S., Maeda S., Osawa T., and Uchida K. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J. Biol. Chem. 274 (1999) 18492-18502
9. Sasaki N., Fukatsu R., Tsuzuki K., Hayashi Y., Yoshida T., Fujii N., Koike T., Wakayama I., Yanagihara R., Garruto R., Amano N., and Makita Z. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am. J. Pathol. 153 (1998) 1149-1155
10. Shipanova I.N., Glomb M.A., and Nagaraj R.H. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch. Biochem. Biophys. 344 (1997) 29-36
11. Westwood M.E., and Thornalley P.J. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation end product-modified serum albumins. J. Protein Chem. 14 (1995) 359-372
12. Van Heijst J.W., Niessen H.W., Hoekman K., and Schalkwijk C.G. Advanced glycation end products in human cancer tissues: detection of N epsilon-(carboxymethyl)lysine and argpyrimidine. Ann. N Y Acad. Sci. 1043 (2005) 725-733
13. Sakamoto H., Mashima T., Yamamoto K., and Tsuruo T. Modulation of heat-shock protein 27 (Hsp27) anti-apoptotic activity by methylglyoxal modification. J. Biol. Chem. 277 (2002) 45770-45775
14. Chen F., Wollmer M.A., Hoerndli F., Munch G., Kuhla B., Rogaev E.I., Tsolaki M., Papassotiropoulos A., and Gotz J. Role for glyoxalase I in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101 (2004) 7687-7692
15. Junaid M.A., Kowal D., Barua M., Pullarkat P.S., Sklower B.S., and Pullarkat R.K. Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am. J. Med. Genet. A 131 (2004) 11-17
16. Hovatta I., Tennant R.S., Helton R., Marr R.A., Singer O., Redwine J.M., Ellison J.A., Schadt E.E., Verma I.M., Lockhart D.J., and Barlow C. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 438 (2005) 662-666
17. Tafti M., Petit B., Chollet D., Neidhart E., de Bilbao F., Kiss J.Z., Wood P.A., and Franken P. Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep. Nat. Genet. 34 (2003) 320-325
18. Kawasaki T., Takagi Y., Yamatani H., and Hirata T. Systematic screening and identification of antigens recognized by monoclonal antibodies raised against the developing lateral olfactory tract. J. Neurobiol. 62 (2005) 330-340
19. Shinohara M., Thornalley P.J., Giardino I., Beisswenger P., Thorpe S.R., Onorato J., and Brownlee M. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation end product formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest. 10 (1998) 1142-1147
20. Principato G.B., Locci P., Rosi G., Talesa V., and Giovannini E. Activity changes of glyoxalases I-II and glutathione reductase in regenerating rat liver. Biochem. Int. 6 (1983) 249-255
21. Konova E., Baydanoff S., Atanasova M., and Velkova A. Age-related changes in the glycation of human aortic elastin. Exp. Gerontol. 39 (2004) 249-254
22. Hammes H.P., Wellensiek B., Kloting I., Sickel E., Bretzel R.G., and Brownlee M. The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster. Diabetologia 41 (1998) 165-170
23. Kawatani M., Okumura H., Honda K., Kanoh N., Muroi M., Dohmae N., Takami M., Kitagawa M., Futamura Y., Imoto M., and Osada H. The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I. Proc. Natl. Acad. Sci. USA 105 (2008) 11691-11696
24. Maeta K., Izawa S., Okazaki S., Kuge S., and Inoue Y. Activity of the Yap1 transcription factor in Saccharomyces cerevisiae is modulated by methylglyoxal, a metabolite derived from glycolysis. Mol. Cell Biol. 24 (2004) 8753-8764